{"name":"Center for Vascular Pathology, Moscow","slug":"center-for-vascular-pathology-moscow","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"Haemoblock","genericName":"Haemoblock","slug":"haemoblock","indication":"Other","status":"marketed"},{"name":"Troxevasin","genericName":"Troxevasin","slug":"troxevasin","indication":"Other","status":"phase_2"}]}],"pipeline":[{"name":"Haemoblock","genericName":"Haemoblock","slug":"haemoblock","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Troxevasin","genericName":"Troxevasin","slug":"troxevasin","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiV0FVX3lxTFA4Q0UtcE0xSk1DSXNSOExSSUtMb2V2dWN1OFlFUVJoTU1YUXNlT19Rbi1USVFnZmlLRENIZ1Q1cHJuOVpNZWtza1VvYjMzNEFWOE1rd0Y3cw?oc=5","date":"2026-03-17","type":"pipeline","source":"Официальный сайт Мэра Москвы","summary":"Sergei Sobyanin: Moscow’s pharmaceutical output of heart and vascular drugs surges / News / Moscow City Web Site - Официальный сайт Мэра Москвы","headline":"Sergei Sobyanin: Moscow’s pharmaceutical output of heart and vascular drugs surges / News / Moscow City Web Site - Офици","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiVEFVX3lxTE1UdHczTEY5bkMyWUhxbHpwMUV1WXVwYmFTSV9WckpndllYQ0duWWZsRFNDajcwWEJnQmRsOXlfcVJVWHBZc3VKSDJaRXdWelVQLWdMaQ?oc=5","date":"2025-10-24","type":"pipeline","source":"Официальный сайт Мэра Москвы","summary":"Moscow companies increase production of pharmaceuticals / News / Moscow City Web Site - Официальный сайт Мэра Москвы","headline":"Moscow companies increase production of pharmaceuticals / News / Moscow City Web Site - Официальный сайт Мэра Москвы","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE1HanBvS2JpRFYyOF9MSG5mNjdJVnloMVJCNWlxb3ZtczBrM1VrOENpRHdQZy1aWDJMeHM2X0tNWEpQbG9qZVlrYjkzaFRGYkdTa1lZbklabENnSVVaZ1NZ?oc=5","date":"2025-05-07","type":"trial","source":"nature.com","summary":"Characterising acute and chronic care needs: insights from the Global Burden of Disease Study 2019 - nature.com","headline":"Characterising acute and chronic care needs: insights from the Global Burden of Disease Study 2019","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiVkFVX3lxTE5WTUxQT2JvYWVFS2VIYUdGUXAySEZMcWVrWWI2d3FKTGp0WXF4UXpFVFlQZjJWMWJ0WHRIRklBenBROU1HdkdOOUlTU2ZVM2Fid3JLN1h3?oc=5","date":"2023-08-25","type":"pipeline","source":"Официальный сайт Мэра Москвы","summary":"Sergei Sobyanin: New pharma factory launched in Technopolis Moscow / News / Moscow City Web Site - Официальный сайт Мэра Москвы","headline":"Sergei Sobyanin: New pharma factory launched in Technopolis Moscow / News / Moscow City Web Site - Официальный сайт Мэра","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibEFVX3lxTE41WWR6M2xTeEhZemVaR0hZTEtQRWFCMXNqOWtxNnFWTXBBb0dEMnk3MGE2cERpZUU4YU5SZmpoMTVUMEI3aGNic1RMaXNVakZ4ZUJBUHpjb1dIUGxOa3dKZ0hjMFlzX0VBOURWQg?oc=5","date":"2021-02-26","type":"pipeline","source":"Wiley Online Library","summary":"Visfatin: An emerging adipocytokine bridging the gap in the evolution of cardiovascular diseases - Wiley Online Library","headline":"Visfatin: An emerging adipocytokine bridging the gap in the evolution of cardiovascular diseases","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"marketed":1,"phase_2":1},"enrichmentLevel":2,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}